NCT00243074 · OUTCOME

Disease Control Rate

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery · Source last updated 2018-01-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: percentage of participants
Interval / dispersion: 95% Confidence Interval
Time frame: Every 8 weeks until disease progression progression, up to 5 years.

What was measured

The percentage of patients with a best of response of stable disease or better per standard RECIST. That is, patients whose best response was not increasing disease or death.

Analysis population: Eligible patients who received AZD2171

Groups in this outcome

AZD2171

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
AZD2171	47

Reported measurements

Source class 1

Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
Group	Value	Spread	Lower	Upper	Comment
AZD2171	44	Not reported	28	58	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
lower Limit
28
upper Limit
58
value
44

denoms

counts
group Id
OG000
value
47
units
Participants

description

The percentage of patients with a best of response of stable disease or better per standard RECIST. That is, patients whose best response was not increasing disease or death.

dispersion Type

95% Confidence Interval

groups

id
OG000
title
AZD2171

param Type

NUMBER

population Description

Eligible patients who received AZD2171

reporting Status

POSTED

time Frame

Every 8 weeks until disease progression progression, up to 5 years.

title

Disease Control Rate

type

SECONDARY

unit Of Measure

percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice